Ryan D'Arcy
Ryan C.N.
≈ 5 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Ryan C.N. D'Arcy (born 19721) is a Canadian neuroscientist, researcher, innovator and entrepreneur. D'Arcy co-founded HealthTech Connex Inc. where he serves as President and Chief Scientific Officer. HealthTech Connex translates neuroscience advancements into health technology breakthroughs.
D'Arcy is most known for coining the term "brain vital signs" and for leading the research and development of the brain vital signs framework. He is also a full tenured professor with appointments at both Simon Fraser University and the University of British Columbia. He holds the Surrey Memorial Hospital Foundation BC Leadership Chair in Multimodal Technology for Healthcare Innovations.
D'Arcy has published more than 300 academic works, generated more than $100 million in competitive research and innovation investment, and has been recognized through numerous national and international awards and distinctions. Throughout his career, D'Arcy has worked to advance brain innovations.
He has advocated for the brain to be monitored regularly to track one's health, and has been focused on optimizing brain health through objective measurements to find the best treatments. His work has involved developing accessible technology improvements for evaluation and treatment in brain injury and concussion, along with other brain conditions such as dementia, epilepsy, brain tumours and stroke.…
Ryan C.N. D'Arcy (born 1972) is a Canadian neuroscientist, researcher, innovator and entrepreneur. D'Arcy co-founded HealthTech Connex Inc. where he serves as President and Chief Scientific Officer. HealthTech Connex translates neuroscience advancements into health technology breakthroughs.
D'Arcy is most known for coining the term "brain vital signs" and for leading the research and development of the brain vital signs framework. He is also a full tenured professor with appointments at both Simon Fraser University and the University of British Columbia. He holds the Surrey Memorial Hospital Foundation BC Leadership Chair in Multimodal Technology for Healthcare Innovations.
D'Arcy has published more than 300 academic works, generated more than $100 million in competitive research and innovation investment, and has been recognized through numerous national and international awards and distinctions. Throughout his career, D'Arcy has worked to advance brain innovations.
He has advocated for the brain to be monitored regularly to track one's health, and has been focused on optimizing brain health through objective measurements to find the best treatments. His work has involved developing accessible technology improvements for evaluation and treatment in brain injury and concussion, along with other brain conditions such as dementia, epilepsy, brain tumours and stroke.
D'Arcy has played roles in advancing Canada's biotechnology industry through founding and co-founding a number of large-scale health-technology initiatives over the course of his career while at the National Research Council Canada (NRC) and Simon Fraser University/Surrey Memorial Hospital. These initiatives include NRC's Institute of Biodiagnostics (Atlantic), now called BIOTIC, and BC's Health and Technology District, encompassing Surrey Memorial Hospital's Health Sciences and Innovation initiative, Innovation Boulevard, the NeuroTech and ImageTech Laboratories, the HealthTech Innovation Hub and the BrainNET initiative.
The Health and Technology District continues to grow towards the planned goals of over 1.5 million square feet of health/technology/innovation space, employing more than 15,000 tech and tech related jobs, and generating more than $1.1 billion into the economy annually.
Brain Vital Signs
Foundational research that led to the concept of brain vital signs started in 1995, with Dr. D’Arcy leading the development of the first rapid, easy, point-of-care measurement of brain waves in 2011. The objective was to utilize electroencephalography (EEG) data, and particularly cognitive evoked potentials (EPs), also known as event-related potentials (ERPs), as an objective physiological measure of brain function.
ERPs were well established but had not been translated into a clinically accessible framework in a manner similar to the measurement of a body's vital signs like blood pressure. D’Arcy’s team developed a new brain vital sign framework specific to the evaluation and monitoring of brain function.
The brain vital signs framework, which derived from the earlier Halifax Consciousness Scanner work, objectively analyze complex EEG data, which then provides simple and objective physiological markers of brain function. The research team subsequently published a series of studies on the development of brain vital signs.
These included the Frontiers in Neuroscience Journal, which remains the most highly accessed paper in the journal's history and ranked in the top 5% of research outputs scored by Altmetrics, and findings from a multi-year hockey concussion study conducted in collaboration with the Mayo Clinic Sports Medicine Center in Brain: A Journal of Neurology. The latter study was the first to demonstrate that brain vital sign monitoring is more sensitive in detecting impairments than existing clinical tests for concussions.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1377498181 under CC BY-SA 4.0; modifications have been made.
References
- ↩Wikipedia “Ryan D'Arcy” date of birth (×1) · confidence 0.95 revision URL